MTAMTech Corp is a leading brand in the field of technology and pharmaceuticals. Founded in 2016 as a spin-off of Taipei Medical University, our team of highly specialized technical members, led by Professor Chen, is dedicated to developing cutting-edge solutions in cancer drug screening. Our mission is to provide patients and drug developers with the most effective and innovative anti-cancer drug screening solutions.

At MTAMTech Corp, we understand the unique needs of patients and drug developers in the fast-paced pharmaceutical industry. We offer a range of products and services that cater to these needs, ensuring that our solutions provide significant value propositions in any segment. Our commitment to scientific and clinical excellence is evident in our multiple publications and collaborations within the field.

Recently, we have focused on the application of our flagship product, MTAM-HFA, in Immuno-Checkpoint Blockers (ICBs), both in combination therapy and non-drug combinations such as irradiation. This demonstrates our dedication to advancing cancer treatment options. Feel free to reach out to our core team members for more information.

Contact us via email at polyjack@mtamtech. com or via phone at +886 911 455155. Join us on our journey as we revolutionize cancer drug screening and treatment